Kristen D. Whitaker, MD, MS

Dr. Whitaker

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111


Assistant Professor


Treatment Focus

Hereditary breast cancer
Breast and Ovary Cancer Risk Assessment

Research Program

Treatment Philosophy

When caring for patients, I get to know them as individuals first. I spend time learning about their beliefs, fears, and support systems before working together as a team to create a treatment plan that provides high quality care that also aligns with their individual desires for their treatment.  I ensure all patients are fully educated on their disease and disease management  so that they are empowered to work together with me to make the best treatment decisions.

I strive to develop a physician-patient relationship centered on compassion, honesty, trust, and mutual respect.  I aim for all my patients to leave their clinic visits knowing that they have been an active participant in their treatment decisions and that they have received the state of the art breast cancer treatments or  the most-up-to-date cancer risk counseling. 

Education and Training

Educational Background

  • Masters of Science in Public Health Sciences for Clinical Professionals, University of Chicago, Chicago, IL, 2016-2019
  • Fellow, Section of Hematology/Oncology, University of Chicago Medicine, Chicago, IL, 2015-2018
  • Resident, Internal Medicine, George Washington University Hospital, Washington, DC, 2012-2015
  • Cancer Clinical Research Assistant, Holy Cross Hospital, Washington, DC, 2006-2007
  • Medical Doctorate, Drexel University College of Medicine, Philadelphia, PA, 2012
  • College of Medicine Post-Baccalaureate Program, Drexel University, Philadelphia, PA, 2008
  • BA, Biological Basis of Behavior, University of Pennsylvania, Philadelphia, PA, 2006


  • Board Certified in Internal Medicine
  • Board Certified in Medical Oncology


  • American Society of Clinical Oncology, 2015-Present
  • American College of Physicians, 2008-Present
  • American Society of Hematology, 2015-Present 
  • National Medical Association, 2013-Present

Honors & Awards

  • Recipient, Best Research Abstract, Clinical Research, Department of Medicine Janet D. Rowley Research Day, University of Chicago, Chicago, IL, 2017
Research Profile

Research Program

Research Interests

  • Genetic predisposition to breast and ovarian cancer
  • Breast cancer screening for high risk women
  • Cancer health disparities
  • Communication of genetic risk within families
Lab Staff

Nicole Ventriglia, BS

Research Study Assistant

Sue Montgomery, RN, BSN, GCN, OCN

Clinical Genetics Nurse Navigator


Selected Publications

Whitaker Kristen, Goldstein Lori. Should Body Mass Index Guide the choice of Chemotherapy in Patients with Breast Cancer? The ASCO Post. 2020 Oct 25.

Whitaker KD, Sheth D, Olopade OI. “Dynamic contrast-enhanced magnetic imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet?” Breast Cancer Rest Treat. 2020 Jul 3.

Kehm RD, Genkinger JM, MacInnis RJ, John EM, Phillips KA, Dite GS, Milne RL, Zeinomar N, Liao Y, Knight JA, Southey MC, Chung WK, Giles GG, McLachlan SA, Whitaker KD, Friedlander M, Weideman PC, Glendon G, Nesci S, Investigators K, Andrulis IL, Buys SS, Daly MB, Hopper JL, Terry MB. “Recreational Physical Activity is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk”. Cancer Res. 2020 Jan 1; 80(1):116-125.

Guindalini, Rodrigo, Zheng Yonglan, Abe, Hiroyuki, Whitaker, Kristen, et al. “Intensive Surveillance with bi-annual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers.” Clin Cancer Res. 2018 Aug 28. doi: 10.1158/1078-0432.CCR-18-0200


Whitaker Kristen, Obeid Elias. “Differences in the Benefit of Multi-Gene Panel(MGP) Genetic Testing between African American and White Women with Invasive Breast cancer”, San Antonio Breast Cancer Symposium, Poster Session, Virtual San Antonio Breast Cancer Symposium, December 2020

Whitaker Kristen, Bernhisel Ryan, Kidd John, Hughes E, Rosenthal Eric, Hall Michael. “A single-institution (N=57 families) and commercial laboratory database(N=586,740) analysis of BRIP1-associated risks”, Poster Session, ASCO Annual Meeting, June 2020

Whitaker Kristen, Obeid Elias, Daly Mary. “Prevalence of HER2 positivity in BRCA-associated breast cancers”, San Antonio Breast Cancer Symposium, San Antonio, TX, December 2019

Whitaker Kristen, Guindalini, Rodrigo, et al. “Breast cancer surveillance in high-risk women with dynamic contrast-enhanced magnetic resonance imaging every 6 months: Results from a single institution study, Poster session, San Antonio Breast Cancer Symposium, San Antonio, TX, December 2017



Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more.


4.9 / 5.0


  • 4.8
  • 4.9
  • 4.8
  • 4.9
  • 4.9


  • 5.0
    December 11, 2021
    Excellent care !!
  • 5.0
    June 14, 2021
    Dr. Whitaker & [...] (her NP) are "wonderful".
  • 5.0
    March 16, 2021
    Everyone is wonderful. Dr. Whitaker is exceptional.
  • No Star Ratings Available January 25, 2021
    Dr. Whitaker always takes as much time is needed to answer all my questions. I would highly recommend her.

Connect with Fox Chase